NDC 0955-3900-01 - Insulin glargine U-300
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0955-3900
- Requested NDC
- 0955-3900-01
- Package NDCs from labels
- 0955-3900-01, 0955-3900-03
- Manufacturer
- Sanofi-Aventis U.S. LLC | Genzyme Corporation | Sanofi-Aventis Deutschland GmbH
- Effective date
- 2025-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Insulin glargine U-300 - Sanofi-Aventis U.S. LLC | Genzyme Corporation | Sanofi-Aventis Deutschland GmbH | Sanofi-Aventis U.S. LLC | Genzyme Corporation | Sanofi-Aventis Deutschland GmbH | 2025-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0955-3900-01 | Insulin glargine U-300 | 1.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 1.5 | 7 | |
| 0955-3900-03 | Insulin glargine U-300 | 3 in 1 CARTON | INJECTION, SOLUTION | 3 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0955-3900 | INSULIN GLARGINE U-300 (INSULIN GLARGINE) INJECTION, SOLUTION INSULIN GLARGINE U-300 MAX (INSULIN GLARGINE) INJECTION, SOLUTION [WINTHROP U.S.] | 6 | Current NDC, 2 package rows | 20240913_99ea856d-9562-443a-9422-1006a3cff2f4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0955-3900-01 | ML - Milliliter | 0955-3900 | 73ddbd73-fc28-4560-b843-3010e4335a91 | 1 | 2024-02-14 |
| 0955-3900-03 | ML - Milliliter | 0955-3900 | c566685f-01f3-4ba5-a58e-23c683d76aec | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Unimed | 3bcd8394-f486-d306-e063-6294a90a4e9a | 2025-08-07 | Warnings | PDC6A3C0OX |
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | KC Pharmaceuticals, Inc. | 3bc03d54-6b31-5921-e063-6294a90af599 | 2025-08-01 | Warnings | PDC6A3C0OX |
| INSULIN GLARGINE | INSULIN GLARGINE-YFGN | Civica, Inc. | 72cfe377-52f6-0348-fc71-5d4ac1992ffb | 2025-07-24 | Warnings, Adverse reactions | 2ZM8CX04RZ |
| Doctor Butler Hemorrhoid and Fissure Advanced Formula | GLYCERIN 37.5%, LANOLIN 12.5%, LIDOCAINE 4%, ZINC OXIDE 5% | Beyond Health, PA | d2a769e2-afd0-aed2-e053-2995a90ad429 | 2025-07-23 | Warnings | PDC6A3C0OX |
| Cold Sore Fast-Acting Pain Relief | GLYCERIN AND LIDOCAINE | Blistex Inc. | c7511322-dd6c-441c-bf7d-ad4f0c14956a | 2025-07-22 | Warnings | PDC6A3C0OX |
| Cureforte Breath Reset | MOUTH SPRAY | STEEL CITY HEALTH PRIVATE LIMITED | 38ddf1a7-29ab-cb8d-e063-6294a90ad34c | 2025-07-21 | Warnings | PDC6A3C0OX |
| GoodSense Hemorrhoidal Pain Relief | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Perrigo Direct, Inc | 2e5f699d-45e8-6451-e063-6394a90a8ad8 | 2025-07-20 | Warnings | PDC6A3C0OX |
| SilkTears | GLYCERIN OPHTHALMIC SOLUTION | SilkTears | 3866e2c1-051b-0b01-e063-6394a90af5cf | 2025-07-16 | Warnings | PDC6A3C0OX |
| Rena-Chord | HOMEOPATHIC LIQUID | Energetix Corporation | 4071f90a-8a28-4338-810b-c9b18cf32f87 | 2025-07-15 | Warnings | J41CSQ7QDS |
| Nikzon Hemorrhoidal | GLYCERIN, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE, AND PRAMOXINE HYDROCHLORIDE | Genomma Lab USA | 8f9a9939-2c99-489f-b597-9a51ec2684f9 | 2025-07-14 | Warnings | PDC6A3C0OX |
| Maximum Strength Hemorrhoidal Cream with Aloe | GLYCERIN, PHENYLEPHINE HCI, PRAMOXINE HCI, PETROLATUM | Chain Drug Marketing Association | 396ea654-8be1-591a-e063-6294a90a11e2 | 2025-07-08 | Warnings | PDC6A3C0OX |
| INSULIN GLARGINE | INSULIN GLARGINE-YFGN | Civica, Inc. | 216f2167-c201-76fe-81ed-0d51fe53832f | 2025-07-03 | Warnings, Adverse reactions | 2ZM8CX04RZ |
| Hemorrhoidal Cream | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 38cf4e43-280b-eb96-e063-6294a90a5949 | 2025-07-02 | Warnings | PDC6A3C0OX |
| SEFUDUN FUNGAL NAIL PATCHES | GLYCERIN | Shenzhen Shandian Jingling Technology Co., Ltd. | 38db97d6-27c8-da99-e063-6294a90aac66 | 2025-07-01 | Warnings | PDC6A3C0OX |
| Glycerin Laxative | GLYCERIN LAXATIVE SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 35cc266a-196f-16ce-e063-6394a90a24af | 2025-06-20 | Warnings | PDC6A3C0OX |
| Lantus Solostar | INSULIN GLARGINE | sanofi-aventis U.S. LLC | d5e07a0c-7e14-4756-9152-9fea485d654a | 2025-06-02 | Warnings, Adverse reactions | 2ZM8CX04RZ |
| TOUJEO | INSULIN GLARGINE | Sanofi-Aventis U.S. LLC | c9561d96-124d-48ca-982f-0aa1575bff36 | 2025-05-30 | Warnings, Adverse reactions | BLA206538 2002419 1604539 2ZM8CX04RZ |
| Insulin glargine U-300 Max | INSULIN GLARGINE | Sanofi-Aventis U.S. LLC | 99ea856d-9562-443a-9422-1006a3cff2f4 | 2025-05-30 | Warnings, Adverse reactions | BLA206538 0955-3900-03 0955-2900-01 0955-2900-02 0955-3900-01 0955-3900 0955-2900 00955390001 2002419 1604539 63c52b96-0bdf-42f0-9c6c-e439846e6926 99ea856d-9562-443a-9422-1006a3cff2f4 2ZM8CX04RZ |
| Code Red Eye Drops Micro | GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE | 4 Trees LLC | 2a15ea9a-ff67-446b-8b83-6517d25ff38a | 2025-05-29 | Warnings | PDC6A3C0OX |
| VACC HC | ANTIMONIUM TARTARICUM, ARSENICUM ALBUM, BRYONIA (ALBA), ECHINACEA (ANGUSTIFOLIA), GELSEMIUM SEMPERVIRENS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYOSCYAMUS NIGER, INFLUENZINUM, LEDUM PALUSTRE, MERCURIUS SOLUBILIS, MEZEREUM, NICOTINAMIDUM, RNA, SENEGA OFFICINALIS, SILICEA, SPIGELIA ANTHELMIA, SULPHUR, THUJA OCCIDENTALIS, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 5e37c522-a821-4673-9220-b59c73957445 | 2025-05-27 | Warnings | J41CSQ7QDS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.